Stephen Franklin

Keine laufenden Positionen mehr

56 Jahre

Health Services

Consumer Services

Health Technology

Ehemalige bekannte Positionen von Stephen Franklin

Unternehmen	Position	Beginn	Ende
Evgen Ltd. Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom.	Direktor/Vorstandsmitglied	01.01.2008	30.04.2020
	Gründer	01.01.2008	30.04.2020
THERACRYF PLC	Direktor/Vorstandsmitglied	02.10.2014	30.04.2020
	Vorstandsvorsitzender	02.10.2014	30.04.2020
	Gründer	01.01.2007	30.04.2020
	Investor Relations Kontakt	-	-
PROVEXIS PLC	Vorstandsvorsitzender	01.09.2002	01.07.2007
PROVEXIS PLC	Gründer	01.09.2002	01.07.2007
ANGLE PLC	Corporate Officer/Principal	01.04.1998	01.09.2002
Manchester Biotech Ltd.	Corporate Officer/Principal	-	-

The University of Nottingham	Masters Business Admin
York University	Undergraduate Degree

International

Vereinigtes Königreich	7
Kanada	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
PROVEXIS PLC	Health Technology
ANGLE PLC	Distribution Services
THERACRYF PLC	Health Services

Private Unternehmen	2
Evgen Ltd. Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom.	Health Services
Manchester Biotech Ltd.

Private Unternehmen

Health Services

Manchester Biotech Ltd.